Pelvic Pain

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
RelugolixPhase 21 trial
Active Trials
NCT06279195Withdrawn0Est. Nov 2025
Revalesio
RevalesioWA - Tacoma
1 program
Electro-kinetically Modified WaterN/A1 trial
Active Trials
NCT02523794TerminatedEst. Sep 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerRelugolix
RevalesioElectro-kinetically Modified Water

Clinical Trials (2)

Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment

Start: Jun 2024Est. completion: Nov 20250
Phase 2Withdrawn
NCT02523794RevalesioElectro-kinetically Modified Water

Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis

Start: Aug 2015Est. completion: Sep 2016
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space